Form 8-K - Current report:
SEC Accession No. 0001193125-26-332736
Filing Date
2026-08-04
Accepted
2026-08-04 16:02:18
Documents
28
Period of Report
2026-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-20260804.htm   iXBRL 8-K 50099
2 EX-99.1 sndx-ex99_1.htm EX-99.1 291320
3 EX-99.2 sndx-ex99_2.htm EX-99.2 17273
4 GRAPHIC img199102934_0.jpg GRAPHIC 14374
5 GRAPHIC sndx-ex99_2s1.jpg GRAPHIC 271529
6 GRAPHIC sndx-ex99_2s2.jpg GRAPHIC 762719
7 GRAPHIC sndx-ex99_2s3.jpg GRAPHIC 452713
8 GRAPHIC sndx-ex99_2s4.jpg GRAPHIC 350154
9 GRAPHIC sndx-ex99_2s5.jpg GRAPHIC 378782
10 GRAPHIC sndx-ex99_2s6.jpg GRAPHIC 293208
11 GRAPHIC sndx-ex99_2s7.jpg GRAPHIC 282978
12 GRAPHIC sndx-ex99_2s8.jpg GRAPHIC 331711
13 GRAPHIC sndx-ex99_2s9.jpg GRAPHIC 548532
14 GRAPHIC sndx-ex99_2s10.jpg GRAPHIC 401020
15 GRAPHIC sndx-ex99_2s11.jpg GRAPHIC 473478
16 GRAPHIC sndx-ex99_2s12.jpg GRAPHIC 312899
17 GRAPHIC sndx-ex99_2s13.jpg GRAPHIC 387015
18 GRAPHIC sndx-ex99_2s14.jpg GRAPHIC 320756
19 GRAPHIC sndx-ex99_2s15.jpg GRAPHIC 227359
20 GRAPHIC sndx-ex99_2s16.jpg GRAPHIC 90394
  Complete submission text file 0001193125-26-332736.txt   8615371

Data Files

Seq Description Document Type Size
21 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sndx-20260804.xsd EX-101.SCH 24852
31 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20260804_htm.xml XML 4682
Mailing Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 261238399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)